PROM1 and colorectal cancer: IL-4 autocrine response mediated colorectal cancer stem-like cell (CSC) survival and chemotherapeutic resistance through protecting the tumorigenic CD133+ CSC apoptosis; blocking or inhibiting IL-4 signaling sensitizes CSCs to apoptosis and increases the efficacy of cytotoxic therapy in vivo [23, 24].